0000835887-13-000005.txt : 20130128 0000835887-13-000005.hdr.sgml : 20130128 20130128151300 ACCESSION NUMBER: 0000835887-13-000005 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506 FILED AS OF DATE: 20130128 DATE AS OF CHANGE: 20130128 EFFECTIVENESS DATE: 20130128 FILER: COMPANY DATA: COMPANY CONFORMED NAME: PROGENICS PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000835887 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133379479 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-190883 FILM NUMBER: 13551391 BUSINESS ADDRESS: STREET 1: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 BUSINESS PHONE: 9147892800 MAIL ADDRESS: STREET 1: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 D 1 primary_doc.xml X0706 D LIVE 0000835887 PROGENICS PHARMACEUTICALS INC 777 OLD SAW MILL RIVER ROAD TARRYTOWN NY NEW YORK 10591 9147892800 DELAWARE None None Corporation true Mark R. Baker 777 Old Saw Mill River Road Tarrytown NY NEW YORK 10591 Executive Officer Director Robert J. Israel 777 Old Saw Mill River Road Tarrytown NY NEW YORK 10591 Executive Officer William C. Olson 777 Old Saw Mill River Road Tarrytown NY NEW YORK 10591 Executive Officer Peter J. Crowley 777 Old Saw Mill River Road Tarrytown NY NEW YORK 10591 Director Paul J. Maddon 777 Old Saw Mill River Road Tarrytown NY NEW YORK 10591 Director Charles A. Baker 777 Old Saw Mill River Road Tarrytown NY NEW YORK 10591 Director Kurt W. Briner 777 Old Saw Mill River Road Tarrytown NY NEW YORK 10591 Director Stephen P. Goff 777 Old Saw Mill River Road Tarrytown NY NEW YORK 10591 Director David A. Scheinberg 777 Old Saw Mill River Road Tarrytown NY NEW YORK 10591 Director Nicole S. Williams 777 Old Saw Mill River Road Tarrytown NY NEW YORK 10591 Director Biotechnology $5,000,001 - $25,000,000 06 false 2013-01-18 false true true Private purchase of stock of private company 0 Indefinite 12922374 Indefinite Issuer's securities issued for private company stock subject to transfer restrictions. Total offering amount includes up to $93 million in contingent potential milestone payments payable in cash or Issuer's stock, at Issuer's option. false 11 0 0 0 Private purchase of stock of private company false PROGENICS PHARMACEUTICALS INC /s/ Angelo Lovallo Angelo Lovallo Treasurer 2013-01-28